CHANDAN
NSEChandan Healthcare Limited (SMALL CAP)
Healthcare>Healthcare>Healthcare Services>Healthcare Service Provider
₹226.80
2.65 (1.18%)
As on 12 Jun 2026
Price History
Market Cap
The total value of all a company's shares of stock. It's a quick way to gauge a company's size and value.
₹555 Cr
SMALL CAP
P/E Ratio
Price-to-Earnings ratio. It shows how much you pay for ₹1 of the company's earnings. A lower P/E might mean it's undervalued, but it varies by industry.
23.3
Industry
The specific business sector the company operates in. Useful for comparing with similar companies.
Healthcare Service Provider
52-Week Range
The highest and lowest price at which the stock has traded in the last year (52 weeks). It helps show how volatile the stock is and where it is currently priced relative to its recent history.
52W Low₹216.55+4.7%
52W High₹280-19.0%
Current Price
₹226.80
Circuit Limits (20%)
The maximum allowed price movement (up or down) in a single trading day to prevent excessive volatility. If the stock hits these limits, trading may be temporarily halted.
Lower Circuit₹181.44
Upper Circuit₹272.16
Reference Price
₹226.80
Investment Checklist
Triple Top on 1D (BREAKOUT CONFIRMED) — target ₹265.3
Head and Shoulders on 1D (BREAKOUT CONFIRMED) — target ₹265.3
Volume divergence: Bullish (price down, volume up)
SuperTrend(10,3): Price below SuperTrend (Industry Standard (Swing/Medium-Term))
SuperTrend(7,3): Price below SuperTrend (Responsive Setting (Day Trading/Short-Term))
Technical Analysis
Technical Analysis
Analysis from 2026-06-12
Confidence
47%
Trend
NEUTRAL
NEUTRAL
Mixed MA signals — sideways/transition | Bullish MA stack (20>50>200)
EMA20
236.22
EMA50
235.4
EMA200
154.4
Price Action
MIXED
NEUTRAL
Higher Highs3
Higher Lows5
Lower Highs5
Lower Lows4
Support & Resistance Levels
Resistance (Above)
₹238.35
₹244.40
₹248.27
₹255.00
₹260.05
Support (Below)
₹225.03
₹217.61
₹210.00
₹191.05
₹184.50
Volume Analysis
TrendINCREASING
Change+83.30%
Unusual VolumeNo
Divergence Detected
Bullish (price down, volume up)
Stop Loss Levels
Fixed Risk
1% Risk₹224.53
3% Risk₹220.00
5% Risk₹215.46
7% Risk (Custom)
₹210.92Technical Levels
1x ATR (Volatility)₹216.06
2x ATR (Swing)₹205.32
3x ATR (Trend)₹194.58
Immediate Support₹225.03
Moving Averages
EMA 200 (Long-term)₹154.40
Financials
Financial data not available
Peer Comparison
Healthcare Service ProviderPeer Comparison
| Symbol | Name | Price | Change |
|---|---|---|---|
| LALPATHLAB | Dr. Lal Path Labs Ltd. | ₹1,601.50 | +0.50% |
| VIJAYA | Vijaya Diagnostic Centre Limited | ₹1,287.20 | +0.63% |
| THYROCARE | Thyrocare Technologies Limited | ₹528.90 | +1.83% |
| NEPHROPLUS | Nephrocare Health Services Limited | ₹748.15 | -0.42% |
| METROPOLIS | Metropolis Healthcare Limited | ₹530.70 | +2.03% |
| KRSNAA | Krsnaa Diagnostics Limited | ₹534.30 | +0.23% |
| SURAKSHA | Suraksha Diagnostic Limited | ₹268.05 | +0.00% |
| 3BBLACKBIO | 3B Blackbio Dx Limited | ₹1,245.40 | -0.69% |
| HEALTHX | Health X Platform Limited | ₹280.90 | +0.90% |
| INVICTA | Invicta Diagnostic Limited | ₹59.95 | -1.72% |
Corporate Information
Large Deals
View AllBulk, Block and Short deals reported for this stock.
Loading Deals...
Announcements
Latest updates
Board Meetings
Upcoming and past meetings
Corporate Events
Upcoming results & meetings
No upcoming events found
We couldn't find any scheduled corporate actions for this symbol at the moment.
Latest News
News for CHANDAN
View All
positive
CNBC TV18 - Markets 22h ago
Why Bajaj Finserv AMC is bullish on banks, NBFCs and the Indian market
Nimesh Chandan, Chief Investment Officer at Bajaj Finserv AMC, said the recent correction has created opportunities in select gold financing companies. However, the fund house remains relatively cautious on jewellery stocks and is more constructive on gold financiers from a long-term perspective.
AONEGOLDAONETOTALAXISGOLDBAJAJFINSVBAJAJHLDNGBANK10ADDBANKBETFBBNPPGOLDBFINVESTCHANDANCHOICEGOLDEGOLDGOLD1GOLD360GOLDADDGOLDBETAGOLDBNDGOLDCASEGOLDETFGROWWGOLDHDFCGOLDHSBCGOLDIVZINGOLDLICMFGOLDLIQUIDBETFLIQUIDCASELTGILTBEESLTGILTCASEMID150CASEMOBANK10MOCAPITALMOGOLDMOIPONIFTYBETFNIFTYCASEQGOLDHALFSELECTIPOSILVERCASESML100CASETATAGOLDTOP100CASETWCGOLDETFUNIONGOLDFinancial ServicesHealthcare
positive
Google News - India Markets 1d ago
Shares to buy or sell: Chandan Taparia of Motilal Oswal recommends three stocks to buy today - 12 June 2026 - Mint
Shares to buy or sell: Chandan Taparia of Motilal Oswal recommends three stocks to buy today - 12 June 2026Mint
CHANDANMOALPHA50MOBANK10MOCAPITALMODEFENCEMOENERGYMOGOLDMOGSECMOHEALTHMOINFRAMOIPOMOLOWVOLMOM100MOM50MOMENTUM50MOMGFMOMIDMTMMOMNCMOMOMENTUMMON100MON50EQUALMONEXT50MONIFTY100MONIFTY500MONQ50MOPSEMOQUALITYMOREALTYMOSERVICEMOSILVERMOSMALL250MOTILALOFSMOTOURMOVALUEFinancial ServicesHealthcare
positive
LiveMint - Markets 8d ago
Shares to buy or sell: Chandan Taparia of Motilal Oswal recommends 3 stocks to buy today amid RBI policy - 5 June 2026
Shares to buy or sell: Chandan Taparia has recommended three stocks to buy today, 5 June 2026 - BSE, Laurus Labs and Exide Industries shares.
BSECHANDANEXIDEINDLAURUSLABSMOALPHA50MOBANK10MOCAPITALMODEFENCEMOENERGYMOGOLDMOGSECMOHEALTHMOINFRAMOIPOMOLOWVOLMOM100MOM50MOMENTUM50MOMGFMOMIDMTMMOMNCMOMOMENTUMMON100MON50EQUALMONEXT50MONIFTY100MONIFTY500MONQ50MOPSEMOQUALITYMOREALTYMOSERVICEMOSILVERMOSMALL250MOTILALOFSMOTOURMOVALUEAutomobile and Auto ComponentsFinancial Services